Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

HEALTHCARE SERVICES GROUP INC
Next earnings Jul 21, 2026 (before open) · consensus $0.23 EPS, $481M rev
Last earnings +18.3% on 2026-04-22
Revenue grew 7.1% YoY.
Middling fundamentals offset by an attractive price (~34% below fair value) — worth a look on the value angle.
Sources: SEC EDGAR (CIK 0000731012, latest 10-Q filed 2026-04-24) · EODHD · as of 6/22/2026, 1:41:27 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
HEALTHCARE SERVICES GROUP INC shows $1.84B in FY2025 revenue (+7.1% YoY), a 3.2% net margin, and 11.6% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.64B | $1.69B | $1.67B | $1.72B | $1.84B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $48.5M | $34.2M | $38.4M | $39.5M | $59.1M |
| Diluted EPS | $0.65 | $0.46 | $0.52 | $0.53 | $0.81 |
| Net margin | 3.0% | 2.0% | 2.3% | 2.3% | 3.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1483 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
| 2026-05-26 | WHALEN THOMAS GERARD Director | Award | 1.97K @ $20.32 | $40.0K |
| 2026-05-26 | Gallagher Thomas Michael Director | Award | 1.97K @ $20.32 | $40.0K |
| 2026-05-26 | Ottaviano Dino D Director | Award | 1.97K @ $20.32 | $40.0K |
| 2026-05-26 | Simmons Kurt JR Director | Award | 1.97K @ $20.32 | $40.0K |
| 2026-05-26 | Grant Laura K Director | Award | 1.97K @ $20.32 | $40.0K |
| 2026-05-26 | Casey Diane S Director | Award | 1.97K @ $20.32 | $40.0K |
| 2026-05-26 | Visconto Jude Director | Award | 1.97K @ $20.32 | $40.0K |
| 2026-05-26 | Castagnino Daniela Director | Award | 1.97K @ $20.32 | $40.0K |